Literature DB >> 12402390

The World Health Organization classification of lymphomas.

Jasminka Jakić-Razumović1, Igor Aurer.   

Abstract

The Revised European-American Classification of Lymphoid Neoplasms (REAL) classification has been validated by a multi-institutional study, and project data showed that it is both reproducible and clinically relevant. The new World Health Organization (WHO) Classification of Neoplastic Diseases of Hematopoietic and Lymphoid Tissues, as a joint project of the Society of Hematopathology and European Association of Hematopathologists, is an update of the REAL classification, with minor changes based on newly available information. We analyzed the incidence of different histological types of non-Hodgkin s lymphomas diagnosed in Zagreb University Hospital Center, which were reclassified according to the WHO classification. Furthermore, we present a conceptual grouping of lymphomas into four categories (indolent, aggressive, highly aggressive, and localized indolent).

Entities:  

Mesh:

Year:  2002        PMID: 12402390

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  5 in total

1.  Primary duodenal follicular lymphoma with late disseminated nodal relapse responsive to rituximab monotherapy: A case report.

Authors:  Fredy Nehme; Kyle Rowe; William Palko; Imad Nassif
Journal:  Mol Clin Oncol       Date:  2017-08-23

2.  Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis.

Authors:  Chao Guo; Ming Gong; Zhenling Li
Journal:  Cancer Manag Res       Date:  2020-07-16       Impact factor: 3.989

3.  Cellular density evaluation for malignant lymphoma using equivalent cross-relaxation rate imaging - initial experience.

Authors:  Hideyuki Nishiofuku; Shigeru Matsushima; Yoshitaka Inaba; Hidekazu Yamaura; Yozo Sato; Yasuo Morishima; Kimihiko Kichikawa
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

4.  High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study.

Authors:  Xiaorong Ma; Yan Xu; Wanggang Zhang; Jin Wang; Xingmei Cao; Yinxia Chen; Aili He; Jie Liu; Jianli Wang; Wanhong Zhao; Yun Yang
Journal:  Med Sci Monit       Date:  2016-05-27

Review 5.  A Rare Case of Composite Dural Extranodal Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Authors:  Mark Bustoros; Benjamin Liechty; David Zagzag; Cynthia Liu; Timothy Shepherd; Deborah Gruber; Bruce Raphael; Dimitris G Placantonakis
Journal:  Front Neurol       Date:  2018-04-24       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.